Mesoblast begins subject enrolment in Phase III back pain treatment trial

cafead

Administrator
Staff member
  • cafead   Jul 22, 2024 at 11:32: AM
via Australia-based Mesoblast has begun subject enrolment in the Phase III clinical trial of rexlemestrocel-L for patients with chronic low back pain (CLBP) caused by inflammatory degenerative disc disease.

article source
 

<